Ditlev Nytoft Rasmussen1, John Gásdal Karstensen2, Lene Buhl Riis3, Jørn Brynskov2, Peter Vilmann2. 1. Department of Gastroenterology and Gastrointestinal Surgery, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark ditlevrasmussen@dadlnet.dk. 2. Gastro Unit, Division of Endoscopy, Copenhagen University Hospital Herlev, Copenhagen, Denmark. 3. Department of Pathology, Copenhagen University Hospital Herlev, Copenhagen, Denmark.
Abstract
BACKGROUND AND AIMS: Confocal laser endomicroscopy is an endoscopic method that provides in vivo real-time imaging of the mucosa at a cellular level, elucidating mucosal changes that are undetectable by white light endoscopy. This paper systematically reviews current indications and perspectives of confocal laser endomicroscopy for inflammatory bowel disease. METHODS: Available literature was searched systematically for studies applying confocal laser endomicroscopy in Crohn's disease or ulcerative colitis. Relevant literature was reviewed and only studies reporting original clinical data were included. Next, eligible studies were analysed with respect to several parameters, such as technique and clinical aim and definitions of outcomes. RESULTS: Confocal laser endomicroscopy has been used for a wide range of purposes in inflammatory bowel disease, covering assessment of inflammatory severity, prediction of therapeutic response and relapse and adenoma surveillance in patients with ulcerative colitis. Methods for measurement of the histological changes ranged from subjective grading to objective quantification analysed by computer-aided models. The studies derived their conclusions from assessment of histological features such as colonic crypts, epithelial gaps and epithelial leakiness to fluorescein. CONCLUSIONS: Confocal laser endomicroscopy remains an experimental but emerging tool for assessment of inflammatory bowel disease. It is the only method that enables in vivo functional assessment of intestinal barrier function. There is great heterogeneity in the literature and no single approach has been validated and reproduced to the level of general acceptance.
BACKGROUND AND AIMS: Confocal laser endomicroscopy is an endoscopic method that provides in vivo real-time imaging of the mucosa at a cellular level, elucidating mucosal changes that are undetectable by white light endoscopy. This paper systematically reviews current indications and perspectives of confocal laser endomicroscopy for inflammatory bowel disease. METHODS: Available literature was searched systematically for studies applying confocal laser endomicroscopy in Crohn's disease or ulcerative colitis. Relevant literature was reviewed and only studies reporting original clinical data were included. Next, eligible studies were analysed with respect to several parameters, such as technique and clinical aim and definitions of outcomes. RESULTS: Confocal laser endomicroscopy has been used for a wide range of purposes in inflammatory bowel disease, covering assessment of inflammatory severity, prediction of therapeutic response and relapse and adenoma surveillance in patients with ulcerative colitis. Methods for measurement of the histological changes ranged from subjective grading to objective quantification analysed by computer-aided models. The studies derived their conclusions from assessment of histological features such as colonic crypts, epithelial gaps and epithelial leakiness to fluorescein. CONCLUSIONS: Confocal laser endomicroscopy remains an experimental but emerging tool for assessment of inflammatory bowel disease. It is the only method that enables in vivo functional assessment of intestinal barrier function. There is great heterogeneity in the literature and no single approach has been validated and reproduced to the level of general acceptance.
Authors: Mazen R Al-Mansour; Antonio Caycedo-Marulanda; Brian R Davis; Abdulrahim Alawashez; Salvatore Docimo; Alia Qureshi; Shawn Tsuda Journal: Surg Endosc Date: 2020-05-13 Impact factor: 4.584
Authors: Hamzah Abu-Sbeih; Faisal S Ali; Dana Alsaadi; Joseph Jennings; Wenyi Luo; Zimu Gong; David M Richards; Aline Charabaty; Yinghong Wang Journal: J Immunother Cancer Date: 2018-12-05 Impact factor: 13.751
Authors: Fredrik Bergenheim; Jakob B Seidelin; Marianne Terndrup Pedersen; Benjamin E Mead; Kim B Jensen; Jeffrey M Karp; Ole Haagen Nielsen Journal: Stem Cell Res Ther Date: 2019-05-27 Impact factor: 6.832
Authors: John Gásdal Karstensen; Tatiana Cârţână; Codruţa Constantinescu; Silviu Dumitrașcu; Bojan Kovacevic; Pia Klausen; Hazem Hassan; Tobias Wirenfeldt Klausen; Helga Bertani; Manoop S Bhutani; Adrian Săftoiu; Peter Vilmann Journal: Endosc Int Open Date: 2018-01-16